Monthly Archives: Januar 2019

CHINA: NEW DEVELOPMENTS FOR PHARMACEUTICAL PATENTS

CHINA: NEW DEVELOPMENTS FOR PHARMACEUTICAL PATENTS

Ticagrelor (trade name Brilinta, Brilique, and Possia) is a blockbuster drug produced by AstraZeneca with total sales of $1,079m in 2017. Ticagrelor: is a platelet aggregation inhibitor and is used for the prevention of thrombotic events (for example stroke or heart attack) in people with acute coronary syndrome or myocardial infarction with ST elevation.